<DOC>
	<DOCNO>NCT01014858</DOCNO>
	<brief_summary>To demonstrate superiority donepezil placebo improve cognitive function , neuropsychiatric burden functional ability people Parkinson 's disease mild dementia 24 month treatment . To demonstrate superiority donepezil placebo improve patient carer quality life establish cost-effectiveness donepezil . To determine instrument suitable evaluate change cognition people Parkinson 's disease mild dementia .</brief_summary>
	<brief_title>Multi-centre UK Study Acetylcholinesterase Inhibitor Donepezil Early Dementia Associated With Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<mesh_term>Cholinesterase Inhibitors</mesh_term>
	<criteria>1 . A diagnosis Parkinson 's disease accord UK Parkinson 's Disease Society Brain Bank Criteria . These criterion standard use throughout NHS UK support NICE guideline . 2 . People mild dementia associate PD , patient and/or family become aware cognitive without behavioural symptom cause functional impairment . `` Dementia '' define accord recently publish Movement Disorder Society Task Force criterion dementia associate Parkinson 's Disease `` operationalised '' use Addenbrooke 's Cognitive Examination ( ACER ) . The ACER permit description dementia profile also quantify global impairment . It increasingly use clinician UK identify demented subject , relatively quick perform ( 15 minute ) , require specific train produce total score ( 0100 ) , MMSE ( 030 ) also extract . Participants ACER 88 less . If criterion meet , subject assess use Mattis Dementia Rating Scale ( DRS2 ) . An age educationcorrected total DRS2 score le 8 great 4 ( correspond 6th 28th percentile ) use define `` mild '' dementia '' . 3 . Communityliving spouse , close relative well establish carer accompany subject act informant . 4 . Where relevant , woman child bear potential must use adequate contraception duration study . 1 . Dementia develop within one year onset motor symptom . The reason `` one year rule '' specifically exclude participant Dementia Lewy Bodies ( DLB ) . This exclusion criterion consistent recommendation make Movement Disorder Society Dementia Task Force Diagnostic Criteria Third Report DLB Consortium . 2 . People severe motor disability , impaired activity daily live aspect PD , would interfere cognitive global assessment . 3 . Severe current depressive episode . Low mood may impact upon accurate cognitive assessment major depression therefore listed feature , present , make impossible reliably diagnose PDD Movement disorder Society Task Force PDD Criteria . This operationalised use selfcompleted Beck Depression Inventory cutoff score 13 , recommend recent Movement Disorder Society Task Force report . The BDI score consider robust face mild moderate cognitive impairment . 4 . Unstable significant medical comorbidity . 5 . Patient receive anticholinergic drug control parkinsonian motor symptom . 6 . Previous exposure cholinesterase inhibitor 7 . Presence condition contraindicative use donepezil ( include clinically significant cardiac conduction defect find patient history screen ECG ) ; see SmPC ( Appendix W ) detail . 8 . Allergy/hypersensitivity excipients donepezil placebo 9 . Patient receive Nmethyldaspartate antagonist memantine . 10 . Previous neurosurgery Parkinson 's disease . This apply small minority predominantly young case . The main reason exclusion relate ongoing uncertainty potential confounding effect deep brain stimulation upon mood cognition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>mild dementia</keyword>
	<keyword>donepezil</keyword>
	<keyword>NIHR HTA</keyword>
</DOC>